InsiderClue
Insiders · Profile

BRATTON DOUGLAS K

10% owner at Denali Therapeutics · Director at Aquestive Therapeutics. Filing since 12 Dec 2017. CIK 0001281933

DNLI Denali Therapeutics Inc. 10% owner · 13 trades AQST Aquestive Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
DNLI Denali Therapeutics Inc.
12 Feb 2021
10% owner
Sold, plan not stated
2,216,798
$144.09M
18.2%
DNLI Denali Therapeutics Inc.
14 Dec 2020
10% owner
Sold, plan not stated
17,825
$1.43M
4.4%
DNLI Denali Therapeutics Inc.
11 Dec 2020
10% owner
Sold, plan not stated
46,799
$3.75M
10.4%
DNLI Denali Therapeutics Inc.
12 Aug 2020
10% owner
Sold, plan not stated
1,443,247
$45.68M
10.6%
DNLI Denali Therapeutics Inc.
30 Jun 2020
10% owner
Sold, plan not stated
45,345
$1.09M
9.2%
DNLI Denali Therapeutics Inc.
29 Jun 2020
10% owner
Sold, plan not stated
82,578
$1.98M
14.3%
DNLI Denali Therapeutics Inc.
26 Jun 2020
10% owner
Sold, plan not stated
122,077
$2.92M
17.5%
DNLI Denali Therapeutics Inc.
23 Jun 2020
10% owner
Sold, plan not stated
20,024
$515.97K
2.8%
DNLI Denali Therapeutics Inc.
22 Jun 2020
10% owner
Sold, plan not stated
90,056
$2.23M
11.1%
DNLI Denali Therapeutics Inc.
19 Jun 2020
10% owner
Sold, plan not stated
144,920
$3.56M
15.2%
DNLI Denali Therapeutics Inc.
5 Jun 2020
10% owner
Sold, plan not stated
1,922,855
$49.51M
12.4%
DNLI Denali Therapeutics Inc.
26 Feb 2020
10% owner
Sold, plan not stated
3,894,764
$78.87M
20.0%
AQST Aquestive Therapeutics, Inc.
24 Jul 2018
Director
Bought
165,000
$2.48M
opened
DNLI Denali Therapeutics Inc.
12 Dec 2017
10% owner
Bought
275,000
$4.95M
1.4%
14 decisions on file.